Replication failure, genome instability, and increased cancer susceptibility in mice with a point mutation in the DNA ligase I gene

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• DNA ligase I is essential for joining DNA replication intermediates.
• A human patient with immunodeficiency presented with accumulated replication intermediates due to a DNA ligase I mutation.
• Understanding DNA ligase I's role is critical for comprehending DNA replication and cancer development.

Purpose of the Study:

• To investigate the in vivo function of DNA ligase I using a gene-targeted mouse model.
• To determine the consequences of impaired DNA ligase I activity on DNA replication, genome stability, and cancer incidence.
• To establish a mouse model for studying the link between genome instability and cancer.

Main Methods:

• Gene targeting was used to introduce a specific point mutation into the mouse DNA ligase I gene.
• Phenotypic analysis of mutant mice included growth rates, hematopoietic function, and cell cycle analysis (sub-G1 population).
• Assessment of genome instability and cancer incidence in mutant mice.

Main Results:

• Mutant mice displayed slower growth and hematopoietic defects during high DNA replication demand.
• Accumulation of a non-apoptotic sub-G1 cell population, potentially indicating single-strand DNA breaks, was observed in spleen and thymus.
• Elevated genome instability and increased incidence of spontaneous epithelial cancers, including rare cutaneous adnexal tumors, were noted in mutant mice.

Conclusions:

• DNA ligase I deficiency leads to DNA replication intermediate accumulation, resulting in genome instability and cancer.
• The study provides evidence that impaired DNA ligase I function directly contributes to oncogenesis through genome instability.
• Mutant mice serve as a valuable model for exploring the relationship between genome instability and human cancers.